Clinical Trial Update: SBRT Combined With Thymalfasin for Metastatic Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of stereotactic body radiation therapy (SBRT) with thymalfasin (thymosin alpha-1) for metastatic esophageal ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Thymalfasin (thymosin alpha-1)

Snippet

Sponsor: Hangzhou Cancer Hospital | Conditions: Esophageal Cancer, Metastatic Esophageal Cancer | Phase 2 | Status: UNKNOWN